Atopic dermatitis (AD), more popularly known as eczema, is a chronic relapsing inflammatory skin condition. It is characterized by rash/lesions, itching, and inflammation that ranges in severity. It affects about…
Lisa LiburdOctober 12, 2022
Drug spend in the U.S. is expected to reach up to $600 billion by 2023, with hundreds of high-cost, low-value drugs coming to market each year. That’s why Independence Blue…
IBX Insights TeamMay 13, 2022
For the past few years, health plans have been trying to figure out the best strategies for using biosimilars to help lower how much is spent on specialty drugs and…
Gregory GambesciaOctober 20, 2021
The right medication regimen is a critical part of most treatment plans. This is especially true for our members with long-term, chronic conditions such as diabetes, high blood pressure, and…
Jeffrey GreenJuly 12, 2021
As prescription drug costs continue to rise, employers are looking for ways to manage the total cost of care. Integration may be the answer. Data shows that pharmacy integration can help lower costs…
IBX Insights TeamApril 6, 2021
SARS-CoV-2 is the novel coronavirus responsible for the COVID-19 pandemic that has overwhelmed the global health care system. As of this writing, the CDC reports more than 28 million COVID-19…
Lisa LiburdMarch 1, 2021
The U.S. Food and Drug Administration (FDA) must approve medications and other therapies as safe and effective before they can be sold in the U.S. Back in the late 1980s,…
Gregory GambesciaAugust 27, 2020
At Independence Blue Cross, we are always striving for innovative ways to make specialty drugs more affordable without restricting member access to the medications they need. As part of these…
Gregory GambesciaJuly 28, 2020
Over the past two decades, the prevalence of peanut allergy has tripled. In fact, peanut allergy is the most common food allergy in children, affecting up to 2.5 percent of…
Lisa LiburdApril 9, 2020
